Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:approvedBy |
April 2021
|
| gptkbp:category |
gptkb:COVID-19_pandemic_in_Kazakhstan
|
| gptkbp:clinicalTrialPhase |
Phase III
|
| gptkbp:countryOfOrigin |
gptkb:Kazakhstan
|
| gptkbp:developedBy |
gptkb:Research_Institute_for_Biological_Safety_Problems
|
| gptkbp:dosesRequired |
2
|
| gptkbp:emergencyServices |
gptkb:Kazakhstan
|
| https://www.w3.org/2000/01/rdf-schema#label |
QazCovid-in
|
| gptkbp:intervalBetweenDoses |
21 days
|
| gptkbp:otherName |
gptkb:QazVac
|
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:status |
approved for emergency use in Kazakhstan
|
| gptkbp:storage |
2–8°C
|
| gptkbp:target |
gptkb:COVID-19
|
| gptkbp:type |
vaccine
|
| gptkbp:bfsParent |
gptkb:QazVac
|
| gptkbp:bfsLayer |
7
|